Company Encyclopedia
View More
name
BIOSINO BIO-TEC
08247.HK
Biosino Bio-Technology and Science Incorporation, together with its subsidiaries, manufactures, sells, and distributes in-vitro diagnostic reagents in Mainland China. The company offers clinical chemistry reagents, including single and double reagents, calibrators, QC products, and washing solution detergents; Elisa kits; rapid tests; and analyzers. It also provides medical and medical inspection services; and produces and sells medical instruments. Biosino Bio-Technology and Science Incorporation founded in 1988 and is based in Beijing, the People’s Republic of China.
1.377 T
08247.HKMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
D
BiotechnologyIndustry
Industry Ranking49/52
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-27.27%E
    • Profit Margin-21.03%D
    • Gross Margin39.01%B
  • Growth ScoreE
    • Revenue YoY-20.57%E
    • Net Profit YoY-144.23%E
    • Total Assets YoY-17.36%E
    • Net Assets YoY-25.85%E
  • Cash ScoreE
    • Cash Flow Margin-475.54%E
    • OCF YoY-20.57%E
  • Operating ScoreC
    • Turnover0.46C
  • Debt ScoreD
    • Gearing Ratio64.36%D

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Hong Kong Stock Movement: BIOSINO BIO-TEC rises 11.11%, active capital flow attracts market attention

    BIOSINO BIO-TEC rose by 11.11%; Sihuan Pharmaceutical fell by 1.79%, with a transaction volume of HKD 158 million; BeiGene fell by 1.65%, with a transaction volume of HKD 147 million; Innovent Biologics fell by 0.53%, with a transaction volume of HKD 144 million; CanSino Biologics rose by 0.25%, with a market capitalization of HKD 110.5 billion

    HK Stock Movers Tracker·
    HK
    08247
    +3.77%
    HK Stock Movers Tracker·
    HK
    08247
    +3.77%

    Hong Kong Stock Movement Update: BIOSINO BIO-TEC leads the rise, IVD MEDICAL falls 15%, communication stocks are active

    Hong Kong stock market overview in the past hour shows a clear divergence between the pharmaceutical and technology sectors. The performance of the pharmaceutical sector is mixed, with BIOSINO BIO-TEC leading the gains at 15.89%, while IVD MEDICAL is under pressure, falling by 15.01%. The technology sector, on the other hand, is favored by funds, with ZTE rising by 10.31%, indicating a preference for tech stocks. The overall market rhythm is fast-paced, with noticeable short-term enthusiasm and rapid switching of funds between different sectors. In the past hour, the most notable stock movement is BIOSINO BIO-TEC, which has seen a remarkable increase of 15.89%. Funds seem to have a strong appetite for it, driving the stock price upward continuously. The activity in the pharmaceutical sector has also increased, attracting more short-term funds' attention. Strong stocks: 1. BIOSINO BIO-TEC: Up 15.89%, with significant fund inflow, and the market is full of expectations for its future performance. 2. ZTE: Up 10.31%, the leader of the technology sector, with continuous fund inflow, showing market confidence in tech stocks. Stocks under pressure: 1. IVD MEDICAL: Down 15.01%, a weak representative of the pharmaceutical sector, with significant fund outflow, and market sentiment is cautious

    HK Stock Movers Tracker·
    HK
    08247
    +3.77%
    HK
    01931
    -0.88%
    HK
    00763
    -1.04%
    HK Stock Movers Tracker·
    HK
    08247
    +3.77%
    HK
    01931
    -0.88%
    HK
    00763
    -1.04%

    Hong Kong Stock Movement: BIOSINO BIO-TEC fell 16.67%, with active trading attracting market attention

    BIOSINO BIO-TEC fell 16.67%; Innovent Biologics fell 4.99%, with a transaction volume of HKD 623 million; 3SBio fell 8.09%, with a transaction volume of HKD 596 million; BeiGene fell 4.35%, with a transaction volume of HKD 427 million; CanSino Biologics fell 3.45%, with a market capitalization of HKD 100.6 billion

    HK Stock Movers Tracker·
    HK
    08247
    +3.77%
    HK Stock Movers Tracker·
    HK
    08247
    +3.77%

    Hong Kong Stock Movement: BIOSINO BIO-TEC fell by 10.56%, with active capital flow causing fluctuations

    BIOSINO BIO-TEC fell 10.56%; BeiGene fell 0.83%, with a transaction volume of HKD 395 million; CanSino Biologics fell 1.16%, with a transaction volume of HKD 363 million; 3SBio rose 0.44%, with a transaction volume of HKD 307 million; Innovent Biologics fell 1.16%, with a market value of HKD 153.1 billion

    HK Stock Movers Tracker·
    HK
    08247
    +3.77%
    HK Stock Movers Tracker·
    HK
    08247
    +3.77%

    BIOSINO BIO-TEC released its interim results, with a loss attributable to shareholders of 17.976 million yuan, an increase of 36.37% year-on-year

    According to the Zhitong Finance APP, BIOSINO BIO-TEC released its interim results for the six months ending June 30, 2025, with the group's operating revenue amounting to RMB 95.815 million, a year-on-year decrease of 28.4%; the loss attributable to shareholders was RMB 17.976 million, a year-on-year increase of 36.37%; the loss per share was RMB 0.124

    Zhitong·
    HK
    08247
    +3.77%
    Zhitong·
    HK
    08247
    +3.77%
    © 2025 Longbridge｜Disclaimer